BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12950017)

  • 21. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.
    Pilette C; Rousselet MC; Bedossa P; Chappard D; Oberti F; Rifflet H; Maïga MY; Gallois Y; Calès P
    J Hepatol; 1998 Mar; 28(3):439-46. PubMed ID: 9551682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.
    Hui AY; Liew CT; Go MY; Chim AM; Chan HL; Leung NW; Sung JJ
    Liver Int; 2004 Dec; 24(6):611-8. PubMed ID: 15566512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of histological and immunohistochemical patterns of the liver in posthepatitic and alcoholic cirrhosis by computerized morphometry.
    Vizzotto L; Vertemati M; Gambacorta M; Sabatella G; Spina V; Minola E
    Mod Pathol; 2002 Aug; 15(8):798-806. PubMed ID: 12181264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and pathological study on liver fibrosis in viral hepatitis].
    Xin S; Mao Y; Wang L; Li Y; Li L; Yu H; Zhao M; Zhang S; Wang S; Wang X; Chen L; Zhou X; Zhou Y; Zou Z; Tang S; Huangpu Y; Zhang L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.
    Colmenero J; Bataller R; Sancho-Bru P; Bellot P; Miquel R; Moreno M; Jares P; Bosch J; Arroyo V; Caballería J; Ginès P
    Gastroenterology; 2007 Feb; 132(2):687-97. PubMed ID: 17258719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum interleukin-6 concentrations in patients with alcoholic liver disease].
    Swiatkowska-Stodulska R; Bakowska A
    Pol Merkur Lekarski; 2004 Sep; 17(99):255-9. PubMed ID: 15628053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C.
    Bandara P; George J; McCaughan G; Naidoo D; Lux O; Salonikas C; Kench J; Byth K; Farrell GC
    Liver Int; 2005 Jun; 25(3):518-26. PubMed ID: 15910488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sampling variability of liver fibrosis in chronic hepatitis C.
    Bedossa P; Dargère D; Paradis V
    Hepatology; 2003 Dec; 38(6):1449-57. PubMed ID: 14647056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score?
    Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C
    Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sources of variability in histological scoring of chronic viral hepatitis.
    Rousselet MC; Michalak S; Dupré F; Croué A; Bedossa P; Saint-André JP; Calès P;
    Hepatology; 2005 Feb; 41(2):257-64. PubMed ID: 15660389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus.
    Kumar M; Kumar A; Hissar S; Jain P; Rastogi A; Kumar D; Sakhuja P; Sarin SK
    Liver Int; 2008 May; 28(5):690-8. PubMed ID: 18433395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.